| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.669 | 0.004 | 0.669 | GABA C receptor rho-3 antagonist | 0.465 0.036 CID_81261 | ||
| 0.646 | 0.004 | 0.646 | Peroxidase inhibitor | 0.585 0.005 CID_81261 | ||
| 0.607 | 0.018 | 0.607 | Aldehyde oxidase inhibitor | 0.275 0.074 CID_81261 | ||
| 0.569 | 0.018 | 0.569 | 5 Hydroxytryptamine release stimulant | 0.249 0.089 CID_81261 | ||
| 0.534 | 0.021 | 0.534 | Aryl hydrocarbon receptor agonist | |||
| 0.529 | 0.018 | 0.529 | Calcium channel L-type activator | |||
| 0.511 | 0.009 | 0.511 | Sigma receptor agonist | |||
| 0.525 | 0.024 | 0.525 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.43 0.076 CID_81261 | ||
| 0.505 | 0.031 | 0.505 | 5 Hydroxytryptamine release inhibitor | 0.368 0.1 CID_81261 | ||
| 0.462 | 0.017 | 0.462 | Superoxide dismutase inhibitor | 0.222 0.095 CID_81261 | ||
| 0.43 | 0.005 | 0.43 | GABA C receptor agonist | 0.21 0.019 CID_81261 | ||
| 0.437 | 0.018 | 0.437 | Interleukin 2 agonist | |||
| 0.425 | 0.007 | 0.425 | Lipocortins synthesis antagonist | 0.17 0.08 CID_81261 | ||
| 0.43 | 0.013 | 0.43 | Anesthetic general | |||
| 0.461 | 0.045 | 0.461 | Histamine release inhibitor | 0.216 0.184 CID_81261 | ||
| 0.405 | 0.007 | 0.405 | Interleukin 6 antagonist | |||
| 0.403 | 0.014 | 0.403 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.431 | 0.042 | 0.431 | MAP kinase kinase 6 inhibitor | |||
| 0.399 | 0.016 | 0.399 | ErbB-1 antagonist | |||
| 0.394 | 0.015 | 0.394 | 5 Hydroxytryptamine uptake stimulant | 0.264 0.068 CID_81261 | ||
| 0.397 | 0.018 | 0.397 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.402 | 0.024 | 0.402 | Calcium channel activator | 0.296 0.096 CID_81261 | ||
| 0.396 | 0.019 | 0.396 | Interleukin agonist | 0.176 0.143 CID_81261 | ||
| 0.373 | 0.004 | 0.373 | Carbonic anhydrase XV inhibitor | 0.105 0.061 CID_81261 | ||
| 0.45 | 0.083 | 0.45 | Caspase 9 stimulant | 0.417 0.101 CID_81261 | ||
| 0.398 | 0.038 | 0.398 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.37 | 0.012 | 0.37 | Tyrosine 3 hydroxylase inhibitor | 0.354 0.015 CID_81261 | ||
| 0.373 | 0.016 | 0.373 | MAP kinase kinase 2 inhibitor | 0.165 0.108 CID_81261 | ||
| 0.354 | 0.004 | 0.354 | MAP kinase kinase 3 inhibitor | |||
| 0.36 | 0.011 | 0.36 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.232 0.051 CID_81261 | ||
| 0.372 | 0.028 | 0.372 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.361 | 0.021 | 0.361 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.369 | 0.032 | 0.369 | Dyrk kinase inhibitor | |||
| 0.34 | 0.003 | 0.34 | Toll-Like receptor 3 antagonist | |||
| 0.345 | 0.01 | 0.345 | Neurotrophic factor enhancer | 0.174 0.105 CID_81261 | ||
| 0.339 | 0.005 | 0.339 | Ferrochelatase inhibitor | 0.218 0.019 CID_81261 | ||
| 0.365 | 0.032 | 0.365 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.333 | 0.004 | 0.333 | GABA C receptor rho-2 antagonist | 0.184 0.039 CID_81261 | ||
| 0.347 | 0.018 | 0.347 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.341 | 0.025 | 0.341 | RNA-directed DNA polymerase inhibitor | 0.176 0.14 CID_81261 | ||
| 0.332 | 0.019 | 0.332 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | |||
| 0.318 | 0.004 | 0.318 | GABA C receptor antagonist | 0.221 0.009 CID_81261 | ||
| 0.325 | 0.014 | 0.325 | Alpha-N-acetylglucosaminidase inhibitor | 0.246 0.023 CID_81261 | ||
| 0.31 | 0.003 | 0.31 | HIV-1 integrase (Overall Integration) inhibitor | 0.121 0.039 CID_81261 | ||
| 0.311 | 0.019 | 0.311 | LIM domain kinase 1 inhibitor | |||
| 0.307 | 0.018 | 0.307 | Phospholipase C inhibitor | 0.155 0.096 CID_81261 | ||
| 0.374 | 0.086 | 0.374 | 15-Lipoxygenase inhibitor | |||
| 0.323 | 0.036 | 0.323 | Ca2+/calmodulin-dependent protein kinase inhibitor | |||
| 0.287 | 0.004 | 0.287 | GABA C receptor rho-1 antagonist | 0.135 0.029 CID_81261 | ||
| 0.305 | 0.026 | 0.305 | TRKC antagonist | |||
| 0.301 | 0.024 | 0.301 | Protein kinase C nu inhibitor | |||
| 0.313 | 0.036 | 0.313 | Clk dual-specificity kinase inhibitor | |||
| 0.32 | 0.047 | 0.32 | Insulysin inhibitor | 0.316 0.049 CID_81261 | ||
| 0.29 | 0.019 | 0.29 | I kappa B kinase epsilon inhibitor | |||
| 0.278 | 0.008 | 0.278 | 5 Hydroxytryptamine 3E antagonist | 0.217 0.039 CID_81261 | ||
| 0.319 | 0.05 | 0.319 | DNA damaging | |||
| 0.299 | 0.03 | 0.299 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.299 | 0.032 | 0.299 | CDC-like kinase 4 inhibitor | |||
| 0.282 | 0.016 | 0.282 | Nitric-oxide synthase stimulant | 0.198 0.091 CID_81261 | ||
| 0.286 | 0.022 | 0.286 | Protein kinase (CK1) gamma 1 inhibitor | |||
| 0.306 | 0.042 | 0.306 | DNA synthesis inhibitor | |||
| 0.277 | 0.015 | 0.277 | Succinate dehydrogenase inhibitor | 0.221 0.034 CID_81261 | ||
| 0.266 | 0.004 | 0.266 | 5 Hydroxytryptamine 3A agonist | 0.132 0.047 CID_81261 | ||
| 0.332 | 0.073 | 0.332 | Cholesterol antagonist | |||
| 0.268 | 0.014 | 0.268 | Hexokinase inhibitor | |||
| 0.297 | 0.043 | 0.297 | Psychostimulant | |||
| 0.296 | 0.043 | 0.296 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.29 | 0.04 | 0.29 | Death-associated protein kinase 3 inhibitor | |||
| 0.272 | 0.025 | 0.272 | Amyloid beta precursor protein antagonist | |||
| 0.255 | 0.009 | 0.255 | Carbonic anhydrase III inhibitor | 0.14 0.032 CID_81261 | ||
| 0.269 | 0.025 | 0.269 | Protein kinase (CK1) gamma inhibitor | |||
| 0.25 | 0.009 | 0.25 | Carbonic anhydrase VI inhibitor | 0.083 0.053 CID_81261 | ||
| 0.255 | 0.014 | 0.255 | Cystathionine beta-synthase inhibitor | 0.132 0.05 CID_81261 | ||
| 0.241 | 0.005 | 0.241 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.263 | 0.027 | 0.263 | Ca2+/calmodulin-dependent kinase II delta inhibitor | |||
| 0.247 | 0.012 | 0.247 | Catenin beta inhibitor | |||
| 0.281 | 0.048 | 0.281 | Gastrin inhibitor | 0.231 0.103 CID_81261 | ||
| 0.236 | 0.004 | 0.236 | Glutamate release inhibitor | 0.084 0.077 CID_81261 | ||
| 0.244 | 0.013 | 0.244 | Mannose-6-phosphate isomerase inhibitor | 0.179 0.043 CID_81261 | ||
| 0.254 | 0.026 | 0.254 | Protein kinase (CK1) gamma 3 inhibitor | |||
| 0.259 | 0.033 | 0.259 | Focal adhesion kinase 2 inhibitor | 0.178 0.09 CID_81261 | ||
| 0.25 | 0.026 | 0.25 | Histone acetyltransferase inhibitor | |||
| 0.234 | 0.011 | 0.234 | Adenylate kinase inhibitor | 0.149 0.027 CID_81261 | ||
| 0.231 | 0.01 | 0.231 | CF transmembrane conductance regulator agonist | 0.14 0.096 CID_81261 | ||
| 0.27 | 0.049 | 0.27 | Anticonvulsant | |||
| 0.225 | 0.005 | 0.225 | Phenylalanine 4-hydroxylase inhibitor | 0.2 0.007 CID_81261 | ||
| 0.246 | 0.029 | 0.246 | Amylase inhibitor | |||
| 0.248 | 0.031 | 0.248 | Tumour necrosis factor antagonist | 0.189 0.06 CID_81261 | ||
| 0.226 | 0.009 | 0.226 | Porphobilinogen synthase inhibitor | 0.121 0.028 CID_81261 | ||
| 0.24 | 0.023 | 0.24 | NADPH oxidase inhibitor | |||
| 0.261 | 0.046 | 0.261 | Neuropeptide Y2 antagonist | |||
| 0.304 | 0.092 | 0.304 | Transcription factor NF kappa B inhibitor | |||
| 0.227 | 0.017 | 0.227 | Cathepsin H inhibitor | 0.115 0.082 CID_81261 | ||
| 0.216 | 0.006 | 0.216 | Alcohol oxidase inhibitor | 0.094 0.02 CID_81261 | ||
| 0.254 | 0.044 | 0.254 | CDC-like kinase 2 inhibitor | |||
| 0.231 | 0.024 | 0.231 | Anesthetic local | |||
| 0.231 | 0.025 | 0.231 | Toll-Like receptor 9 antagonist | |||
| 0.216 | 0.011 | 0.216 | Histidine decarboxylase inhibitor | 0.062 0.059 CID_81261 | ||
| 0.211 | 0.01 | 0.211 | Interleukin 8 antagonist | |||
| 0.212 | 0.012 | 0.212 | Carbonic anhydrase XIII inhibitor | |||
| 0.234 | 0.035 | 0.234 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.223 | 0.025 | 0.223 | Interleukin 1 antagonist | |||
| 0.243 | 0.046 | 0.243 | Non-steroidal antiinflammatory agent | 0.169 0.096 CID_81261 | ||
| 0.207 | 0.01 | 0.207 | NADH dehydrogenase inhibitor | 0.118 0.03 CID_81261 | ||
| 0.201 | 0.004 | 0.201 | GABA aminotransferase inhibitor | 0.077 0.051 CID_81261 | ||
| 0.253 | 0.057 | 0.253 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.222 | 0.026 | 0.222 | Protein kinase (CK1) gamma 2 inhibitor | |||
| 0.211 | 0.016 | 0.211 | Nav1.6 sodium channel blocker | |||
| 0.205 | 0.011 | 0.205 | Adenylate cyclase stimulant | 0.157 0.051 CID_81261 | ||
| 0.203 | 0.011 | 0.203 | Protein kinase C zeta inhibitor | |||
| 0.315 | 0.124 | 0.315 | Antibacterial | 0.222 0.205 CID_81261 | ||
| 0.206 | 0.015 | 0.206 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.121 0.038 CID_81261 | ||
| 0.281 | 0.091 | 0.281 | 12-Lipoxygenase inhibitor | 0.195 0.157 CID_81261 | ||
| 0.215 | 0.027 | 0.215 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.205 | 0.017 | 0.205 | UDP-glucose 4-epimerase inhibitor | 0.186 0.02 CID_81261 | ||
| 0.215 | 0.029 | 0.215 | CDC-like kinase 1 inhibitor | |||
| 0.216 | 0.031 | 0.216 | Ribosomal protein S6 kinase inhibitor | |||
| 0.196 | 0.011 | 0.196 | Creatine kinase inhibitor | 0.135 0.031 CID_81261 | ||
| 0.21 | 0.025 | 0.21 | Aldehyde dehydrogenase inhibitor | 0.12 0.071 CID_81261 | ||
| 0.197 | 0.015 | 0.197 | Potassium channel (Ca-activated) activator | |||
| 0.197 | 0.018 | 0.197 | Beta amyloid protein antagonist | |||
| 0.215 | 0.038 | 0.215 | Polo-like kinase-3 inhibitor | |||
| 0.18 | 0.004 | 0.18 | D-Ala-D-Ala ligase inhibitor | 0.099 0.031 CID_81261 | ||
| 0.188 | 0.012 | 0.188 | Phosphodiesterase 7B inhibitor | |||
| 0.205 | 0.029 | 0.205 | Arachidonic acid antagonist | 0.157 0.081 CID_81261 | ||
| 0.277 | 0.108 | 0.277 | Vasodilator, coronary | |||
| 0.176 | 0.007 | 0.176 | Myeloperoxidase inhibitor | 0.087 0.055 CID_81261 | ||
| 0.175 | 0.006 | 0.175 | Carbonic anhydrase VB inhibitor | 0.06 0.035 CID_81261 | ||
| 0.278 | 0.109 | 0.278 | Vasodilator, peripheral | |||
| 0.172 | 0.004 | 0.172 | Granulocyte macrophage colony stimulating factor agonist | 0.107 0.026 CID_81261 | ||
| 0.18 | 0.013 | 0.22 | Triose-phosphate isomerase inhibitor | 0.22 0.009 CID_81261 | CID_81261 | |
| 0.189 | 0.022 | 0.189 | Interleukin 1b antagonist | |||
| 0.18 | 0.014 | 0.18 | DNA repair enzyme inhibitor | |||
| 0.197 | 0.032 | 0.197 | Toll-Like receptor antagonist | |||
| 0.186 | 0.022 | 0.186 | Falcipain 3 inhibitor | |||
| 0.175 | 0.012 | 0.175 | DOPA decarboxylase inhibitor | 0.119 0.047 CID_81261 | ||
| 0.17 | 0.008 | 0.17 | Biliverdin reductase inhibitor | 0.082 0.025 CID_81261 | ||
| 0.17 | 0.008 | 0.17 | Acetylcholine release stimulant | |||
| 0.169 | 0.007 | 0.169 | Lanosterol 14 alpha demethylase inhibitor | 0.099 0.057 CID_81261 | ||
| 0.171 | 0.01 | 0.171 | MAP kinase kinase 1 inhibitor | 0.127 0.029 CID_81261 | ||
| 0.18 | 0.019 | 0.18 | Protein kinase C gamma inhibitor | |||
| 0.229 | 0.068 | 0.234 | Pyruvate kinase inhibitor | 0.234 0.066 CID_81261 | CID_81261 | |
| 0.175 | 0.015 | 0.175 | Nitric-oxide synthase inhibitor | |||
| 0.179 | 0.018 | 0.179 | Photosensitizer | 0.124 0.052 CID_81261 | ||
| 0.187 | 0.028 | 0.187 | Adenylate cyclase inhibitor | 0.115 0.071 CID_81261 | ||
| 0.171 | 0.012 | 0.171 | Ca2+-transporting ATPase inhibitor | 0.152 0.038 CID_81261 | ||
| 0.218 | 0.06 | 0.218 | DNA methyltransferase I inhibitor | |||
| 0.273 | 0.115 | 0.273 | Prostaglandin dehydrogenase inhibitor | |||
| 0.253 | 0.098 | 0.253 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.182 | 0.026 | 0.182 | Cyclooxygenase 3 inhibitor | |||
| 0.168 | 0.012 | 0.168 | CYP2A6 inhibitor | 0.098 0.037 CID_81261 | ||
| 0.197 | 0.042 | 0.197 | Lck kinase inhibitor | |||
| 0.187 | 0.033 | 0.227 | MAP kinase kinase inhibitor | 0.227 0.02 CID_81261 | CID_81261 | |
| 0.201 | 0.049 | 0.201 | Heat shock protein 90 alpha antagonist | 0.195 0.052 CID_81261 | ||
| 0.166 | 0.014 | 0.166 | Electrolyte absorption antagonist | 0.088 0.077 CID_81261 | ||
| 0.167 | 0.018 | 0.167 | Telomerase inhibitor | |||
| 0.16 | 0.011 | 0.16 | Histamine N-methyltransferase inhibitor | |||
| 0.19 | 0.042 | 0.19 | Activin receptor-like kinase 2 inhibitor | |||
| 0.155 | 0.006 | 0.155 | NMDA 2C receptor antagonist | |||
| 0.154 | 0.007 | 0.154 | Purinergic P2X1 antagonist | 0.064 0.037 CID_81261 | ||
| 0.16 | 0.014 | 0.16 | NMDA 2 receptor antagonist | |||
| 0.215 | 0.069 | 0.215 | DNA methylase inhibitor | |||
| 0.158 | 0.013 | 0.158 | Carbonic anhydrase V inhibitor | 0.061 0.052 CID_81261 | ||
| 0.174 | 0.029 | 0.174 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.148 | 0.004 | 0.148 | Sodium/calcium exchanger inhibitor | |||
| 0.189 | 0.046 | 0.189 | MAP kinase kinase 5 inhibitor | |||
| 0.186 | 0.044 | 0.186 | Neurotensin receptor agonist | |||
| 0.157 | 0.017 | 0.157 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.143 | 0.004 | 0.143 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.11 0.008 CID_81261 | ||
| 0.185 | 0.047 | 0.185 | Protein kinase stimulant | 0.167 0.057 CID_81261 | ||
| 0.162 | 0.025 | 0.162 | Heat shock protein 70 antagonist | |||
| 0.186 | 0.049 | 0.186 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | |||
| 0.144 | 0.009 | 0.144 | NMDA receptor agonist | 0.09 0.023 CID_81261 | ||
| 0.154 | 0.019 | 0.154 | Alcohol dehydrogenase inhibitor | |||
| 0.221 | 0.086 | 0.221 | Antiamyloidogenic | |||
| 0.139 | 0.005 | 0.139 | Topoisomerase II beta inhibitor | |||
| 0.145 | 0.012 | 0.145 | Carbonic anhydrase VA inhibitor | 0.063 0.055 CID_81261 | ||
| 0.177 | 0.044 | 0.177 | Nav1.2 sodium channel blocker | |||
| 0.185 | 0.052 | 0.229 | ATPase inhibitor | 0.229 0.02 CID_81261 | CID_81261 | |
| 0.137 | 0.005 | 0.137 | NMDA receptor glycine site agonist | 0.103 0.015 CID_81261 | ||
| 0.164 | 0.032 | 0.17 | Aminopeptidase B inhibitor | 0.17 0.03 CID_81261 | CID_81261 | |
| 0.176 | 0.044 | 0.176 | Hemostatic | |||
| 0.17 | 0.039 | 0.17 | Neuropeptide Y1 antagonist | |||
| 0.139 | 0.008 | 0.139 | Glycine receptor agonist | 0.078 0.041 CID_81261 | ||
| 0.202 | 0.071 | 0.202 | Insulin sensitizer | |||
| 0.179 | 0.05 | 0.179 | Heat shock protein 90 antagonist | 0.148 0.077 CID_81261 | ||
| 0.147 | 0.019 | 0.147 | Phosphofructokinase-1 inhibitor | 0.093 0.034 CID_81261 | ||
| 0.136 | 0.009 | 0.136 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.072 0.024 CID_81261 | ||
| 0.165 | 0.038 | 0.165 | MAP kinase kinase 4 inhibitor | |||
| 0.134 | 0.008 | 0.134 | NMDA 2A receptor antagonist | |||
| 0.165 | 0.039 | 0.202 | Alkylator | 0.202 0.026 CID_81261 | CID_81261 | |
| 0.229 | 0.105 | 0.306 | Immunostimulant | 0.306 0.077 CID_81261 | CID_81261 | |
| 0.15 | 0.028 | 0.15 | Pim-1 kinase inhibitor | |||
| 0.136 | 0.013 | 0.136 | Carbamoyl phosphate synthetase inhibitor | 0.072 0.033 CID_81261 | ||
| 0.141 | 0.019 | 0.141 | I kappa B kinase inhibitor | |||
| 0.262 | 0.141 | 0.262 | Calpain 2 inhibitor | |||
| 0.225 | 0.105 | 0.225 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.138 | 0.018 | 0.138 | Glutamate dehydrogenase inhibitor | 0.075 0.049 CID_81261 | ||
| 0.168 | 0.049 | 0.168 | Cell wall synthesis inhibitor | |||
| 0.153 | 0.034 | 0.153 | MAP kinase 13 inhibitor | |||
| 0.146 | 0.027 | 0.146 | Catalase inhibitor | |||
| 0.131 | 0.014 | 0.131 | Argininosuccinate synthase inhibitor | 0.056 0.04 CID_81261 | ||
| 0.165 | 0.049 | 0.165 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.144 | 0.028 | 0.155 | Transcription factor STAT6 inhibitor | 0.155 0.02 CID_81261 | CID_81261 | |
| 0.135 | 0.02 | 0.135 | Inducible nitric-oxide synthase inhibitor | |||
| 0.194 | 0.079 | 0.194 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | |||
| 0.119 | 0.004 | 0.119 | Dihydropteroate synthase inhibitor | |||
| 0.163 | 0.048 | 0.163 | Acetylcholinesterase inhibitor | |||
| 0.163 | 0.051 | 0.163 | Cyclooxygenase 1 inhibitor | 0.123 0.077 CID_81261 | ||
| 0.15 | 0.038 | 0.15 | Alpha 2b adrenoreceptor antagonist | |||
| 0.139 | 0.027 | 0.139 | Prolactin inhibitor | 0.086 0.072 CID_81261 | ||
| 0.124 | 0.012 | 0.124 | Acyl-CoA dehydrogenase inhibitor | 0.055 0.037 CID_81261 | ||
| 0.139 | 0.028 | 0.139 | NMDA receptor antagonist | 0.111 0.04 CID_81261 | ||
| 0.158 | 0.047 | 0.158 | Toll-Like receptor 2 antagonist | |||
| 0.126 | 0.015 | 0.126 | Interferon agonist | |||
| 0.116 | 0.006 | 0.116 | Glutamate (mGluR6) antagonist | 0.074 0.032 CID_81261 | ||
| 0.146 | 0.036 | 0.146 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.162 | 0.052 | 0.162 | Alkaline phosphatase inhibitor | |||
| 0.114 | 0.005 | 0.114 | Glutamate (mGluR7) antagonist | 0.073 0.037 CID_81261 | ||
| 0.17 | 0.062 | 0.17 | Cytidine deaminase inhibitor | |||
| 0.13 | 0.022 | 0.13 | Glutamate (mGluR7) agonist | |||
| 0.132 | 0.025 | 0.132 | Pim-3 kinase inhibitor | |||
| 0.137 | 0.03 | 0.163 | Sphingomyelinase inhibitor | 0.163 0.02 CID_81261 | CID_81261 | |
| 0.125 | 0.019 | 0.137 | Glutamate decarboxylase inhibitor | 0.137 0.016 CID_81261 | CID_81261 | |
| 0.123 | 0.016 | 0.123 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.133 | 0.029 | 0.133 | Anabolic | 0.089 0.08 CID_81261 | ||
| 0.115 | 0.011 | 0.115 | Alpha 2 adrenoreceptor agonist | |||
| 0.111 | 0.007 | 0.111 | Aconitate hydratase inhibitor | 0.073 0.017 CID_81261 | ||
| 0.113 | 0.01 | 0.113 | GABA B receptor agonist | 0.09 0.026 CID_81261 | ||
| 0.12 | 0.017 | 0.12 | mTOR complex 2 inhibitor | |||
| 0.146 | 0.044 | 0.146 | MAP kinase 12 inhibitor | |||
| 0.127 | 0.026 | 0.127 | Potassium channel (Voltage-sensitive) activator | |||
| 0.166 | 0.064 | 0.166 | Diuretic | |||
| 0.139 | 0.038 | 0.139 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.156 | 0.055 | 0.156 | Tubulin antagonist | |||
| 0.109 | 0.008 | 0.109 | CD45 antagonist | |||
| 0.118 | 0.017 | 0.118 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.109 | 0.01 | 0.109 | I kappa B kinase 2 inhibitor | |||
| 0.11 | 0.012 | 0.11 | 5 Hydroxytryptamine 3 agonist | |||
| 0.111 | 0.013 | 0.111 | Secretase beta inhibitor | |||
| 0.136 | 0.038 | 0.136 | Check point kinase 2 inhibitor | |||
| 0.155 | 0.058 | 0.155 | Cytokine production inhibitor | |||
| 0.139 | 0.042 | 0.139 | GABA receptor agonist | |||
| 0.137 | 0.04 | 0.137 | Mucolytic | |||
| 0.107 | 0.01 | 0.12 | AMPA receptor antagonist | 0.12 0.009 CID_81261 | CID_81261 | |
| 0.111 | 0.015 | 0.111 | Estrogen-related receptor beta agonist | 0.082 0.06 CID_81261 | ||
| 0.161 | 0.065 | 0.161 | Interferon gamma antagonist | |||
| 0.101 | 0.006 | 0.101 | Transcription factor RelA inhibitor | 0.064 0.044 CID_81261 | ||
| 0.147 | 0.053 | 0.147 | Glutamate receptor antagonist | |||
| 0.098 | 0.004 | 0.098 | Immunoglobulin Fc receptor antagonist | 0.084 0.005 CID_81261 | ||
| 0.104 | 0.01 | 0.104 | MAP kinase kinase 7 inhibitor | |||
| 0.16 | 0.066 | 0.16 | Acetylcholine M1 receptor antagonist | |||
| 0.1 | 0.007 | 0.1 | Epithelial sodium channel blocker | |||
| 0.166 | 0.073 | 0.166 | Src kinase inhibitor | |||
| 0.105 | 0.012 | 0.105 | Phospholipase D inhibitor | 0.069 0.056 CID_81261 | ||
| 0.148 | 0.056 | 0.148 | Pregnane X receptor agonist | |||
| 0.135 | 0.043 | 0.135 | MAP kinase 9 inhibitor | |||
| 0.096 | 0.005 | 0.096 | Adenylate cyclase 1 inhibitor | 0.061 0.017 CID_81261 | ||
| 0.098 | 0.007 | 0.098 | Lysine-specific demethylase 1A inhibitor | |||
| 0.154 | 0.064 | 0.154 | Protein kinase (CK1) inhibitor | |||
| 0.154 | 0.064 | 0.154 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.105 | 0.016 | 0.142 | Histone deacetylase inhibitor | 0.142 0.009 CID_81261 | CID_81261 | |
| 0.103 | 0.014 | 0.103 | Potassium channel (ATP-sensitive) blocker | |||
| 0.214 | 0.126 | 0.214 | Lipoxygenase inhibitor | 0.208 0.132 CID_81261 | ||
| 0.095 | 0.007 | 0.095 | Potassium channel small-conductance Ca-activated blocker | |||
| 0.152 | 0.064 | 0.194 | MAP kinase 3 inhibitor | 0.194 0.027 CID_81261 | CID_81261 | |
| 0.096 | 0.009 | 0.096 | Cyclin D1 inhibitor | |||
| 0.093 | 0.006 | 0.093 | Dihydroorotate oxidase inhibitor | 0.079 0.011 CID_81261 | ||
| 0.092 | 0.005 | 0.092 | Ryanodine receptor antagonist | 0.068 0.02 CID_81261 | ||
| 0.153 | 0.066 | 0.153 | Thiol protease inhibitor | |||
| 0.126 | 0.04 | 0.129 | Urease inhibitor | 0.129 0.037 CID_81261 | CID_81261 | |
| 0.09 | 0.004 | 0.09 | Alpha 1d adrenoreceptor agonist | 0.052 0.015 CID_81261 | ||
| 0.126 | 0.04 | 0.126 | MAP kinase 8 inhibitor | |||
| 0.132 | 0.046 | 0.132 | TRPA1 agonist | 0.098 0.091 CID_81261 | ||
| 0.176 | 0.091 | 0.176 | Amyloid beta aggregation inhibitor | |||
| 0.09 | 0.005 | 0.09 | Dopamine D5 agonist | 0.047 0.02 CID_81261 | ||
| 0.09 | 0.005 | 0.09 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.199 | 0.114 | 0.199 | Calpain inhibitor | |||
| 0.096 | 0.012 | 0.096 | Carbonic anhydrase XIV inhibitor | |||
| 0.105 | 0.021 | 0.105 | T cell inhibitor | |||
| 0.105 | 0.021 | 0.105 | Aromatase inhibitor | |||
| 0.131 | 0.048 | 0.131 | Polo-like kinase-4 inhibitor | |||
| 0.116 | 0.033 | 0.116 | Thioredoxin inhibitor | |||
| 0.136 | 0.053 | 0.136 | Monophenol monooxygenase inhibitor | |||
| 0.112 | 0.029 | 0.112 | Bromodomain-containing protein 2 inhibitor | |||
| 0.139 | 0.057 | 0.139 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.094 | 0.012 | 0.094 | Exportin-1 inhibitor | |||
| 0.106 | 0.025 | 0.106 | Aminopeptidase I inhibitor | 0.073 0.05 CID_81261 | ||
| 0.095 | 0.014 | 0.095 | Interferon inducer | |||
| 0.108 | 0.028 | 0.108 | Histamine H2 receptor antagonist | |||
| 0.094 | 0.013 | 0.094 | Heat shock protein 90 beta antagonist | |||
| 0.111 | 0.03 | 0.111 | Bile acid receptor antagonist | |||
| 0.129 | 0.048 | 0.129 | MAO A inhibitor | |||
| 0.084 | 0.004 | 0.084 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.048 0.017 CID_81261 | ||
| 0.137 | 0.057 | 0.137 | Nav1.3 sodium channel blocker | |||
| 0.228 | 0.149 | 0.228 | Apoptosis antagonist | |||
| 0.133 | 0.053 | 0.133 | Protein kinase (CK2) alpha inhibitor | |||
| 0.106 | 0.027 | 0.106 | Glycine receptor antagonist | 0.09 0.042 CID_81261 | ||
| 0.281 | 0.202 | 0.281 | MAP kinase 1 inhibitor | |||
| 0.146 | 0.067 | 0.146 | Protein-tyrosine kinase Lyn inhibitor | |||
| 0.082 | 0.004 | 0.082 | Glutamate (mGluR8) agonist | 0.039 0.023 CID_81261 | ||
| 0.087 | 0.009 | 0.087 | Kainate receptor antagonist | 0.069 0.013 CID_81261 | ||
| 0.207 | 0.129 | 0.211 | Transcription factor STAT inhibitor | 0.211 0.122 CID_81261 | CID_81261 | |
| 0.124 | 0.046 | 0.124 | Nav1.1 sodium channel blocker | |||
| 0.089 | 0.012 | 0.089 | NMDA receptor subunit 3B antagonist | |||
| 0.086 | 0.01 | 0.086 | Calcium channel P-type blocker | |||
| 0.086 | 0.01 | 0.086 | NMDA receptor subunit 3A antagonist | |||
| 0.088 | 0.012 | 0.088 | Sphingosine kinase 2 inhibitor | |||
| 0.094 | 0.019 | 0.094 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | |||
| 0.081 | 0.006 | 0.081 | AMPA 4 receptor antagonist | |||
| 0.11 | 0.036 | 0.11 | Phosphodiesterase 6D inhibitor | |||
| 0.122 | 0.048 | 0.122 | Alpha 2c adrenoreceptor antagonist | |||
| 0.081 | 0.007 | 0.081 | AICAR transformylase inhibitor | |||
| 0.102 | 0.029 | 0.102 | Purinergic P2X2 antagonist | |||
| 0.123 | 0.05 | 0.123 | Nav1.5 sodium channel blocker | |||
| 0.078 | 0.005 | 0.078 | Dihydrofolate reductase inhibitor | |||
| 0.122 | 0.049 | 0.122 | Expectorant | |||
| 0.077 | 0.004 | 0.077 | Nerve growth factor antagonist | |||
| 0.084 | 0.012 | 0.084 | Glutamate (mGluR group III) agonist | |||
| 0.078 | 0.005 | 0.078 | Potassium channel small-conductance Ca-activated activator | 0.034 0.019 CID_81261 | ||
| 0.1 | 0.028 | 0.1 | Alpha adrenoreceptor agonist | |||
| 0.097 | 0.026 | 0.097 | CC chemokine 5 receptor agonist | 0.077 0.075 CID_81261 | ||
| 0.096 | 0.025 | 0.096 | I kappa B kinase 1 inhibitor | |||
| 0.173 | 0.102 | 0.173 | Interleukin antagonist | |||
| 0.076 | 0.005 | 0.076 | Cytokine production stimulant | 0.046 0.042 CID_81261 | ||
| 0.104 | 0.034 | 0.104 | Acetylcholine nicotinic agonist | |||
| 0.194 | 0.124 | 0.194 | Spasmolytic | |||
| 0.136 | 0.066 | 0.136 | MAO inhibitor | |||
| 0.099 | 0.029 | 0.099 | Thioredoxin reductase inhibitor | |||
| 0.078 | 0.008 | 0.078 | Thymidylate synthase inhibitor | 0.057 0.02 CID_81261 | ||
| 0.122 | 0.053 | 0.122 | Vascular endothelial growth factor 1 antagonist | |||
| 0.125 | 0.056 | 0.125 | Microtubule formation inhibitor | |||
| 0.201 | 0.133 | 0.201 | Transcription factor STAT3 inhibitor | |||
| 0.096 | 0.028 | 0.096 | Adenosine A3 receptor antagonist | |||
| 0.087 | 0.02 | 0.087 | 5 Hydroxytryptamine 6 antagonist | 0.066 0.032 CID_81261 | ||
| 0.175 | 0.108 | 0.175 | Angiogenesis stimulant | |||
| 0.083 | 0.016 | 0.083 | Gonadotropin-releasing hormone receptor agonist | |||
| 0.083 | 0.016 | 0.083 | Potassium channel (Ca-activated) blocker | |||
| 0.087 | 0.02 | 0.087 | Phosphodiesterase VII inhibitor | |||
| 0.105 | 0.039 | 0.105 | Phosphodiesterase I inhibitor | |||
| 0.083 | 0.017 | 0.083 | MDM2 inhibitor | |||
| 0.107 | 0.042 | 0.107 | Potassium channel activator | |||
| 0.127 | 0.062 | 0.127 | TRKA antagonist | |||
| 0.089 | 0.025 | 0.089 | Adenosine A1 receptor antagonist | |||
| 0.121 | 0.057 | 0.121 | DNA intercalator | |||
| 0.085 | 0.021 | 0.085 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.109 | 0.046 | 0.109 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.069 | 0.007 | 0.069 | Diamine oxidase inhibitor | |||
| 0.092 | 0.031 | 0.092 | Protein kinase B beta inhibitor | |||
| 0.11 | 0.049 | 0.11 | Folate antagonist | |||
| 0.086 | 0.024 | 0.086 | Carbonic anhydrase IX inhibitor | |||
| 0.07 | 0.008 | 0.07 | Geranyltranstransferase inhibitor | |||
| 0.098 | 0.037 | 0.098 | MAP kinase 11 inhibitor | |||
| 0.147 | 0.086 | 0.147 | Melanin inhibitor | 0.139 0.098 CID_81261 | ||
| 0.084 | 0.023 | 0.084 | Maillard reaction inhibitor | |||
| 0.138 | 0.077 | 0.138 | Vascular endothelial growth factor 3 antagonist | |||
| 0.143 | 0.082 | 0.143 | Cholinergic | |||
| 0.125 | 0.065 | 0.125 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | |||
| 0.124 | 0.065 | 0.124 | Abl kinase inhibitor | |||
| 0.078 | 0.019 | 0.078 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.114 | 0.055 | 0.114 | MAP kinase kinase kinase inhibitor | |||
| 0.081 | 0.021 | 0.081 | GABA receptor antagonist | 0.057 0.035 CID_81261 | ||
| 0.07 | 0.01 | 0.07 | Histamine H2 receptor agonist | |||
| 0.079 | 0.02 | 0.079 | Phosphodiesterase 1C inhibitor | 0.061 0.045 CID_81261 | ||
| 0.112 | 0.054 | 0.112 | Protein kinase (CK2) inhibitor | |||
| 0.117 | 0.059 | 0.117 | CDK3/cyclin E inhibitor | |||
| 0.077 | 0.019 | 0.078 | Potassium channel intermediate-conductance Ca-activated blocker | 0.078 0.019 CID_81261 | CID_81261 | |
| 0.074 | 0.016 | 0.074 | Prolactin release inhibitor | |||
| 0.079 | 0.022 | 0.079 | GABA A receptor antagonist | 0.05 0.04 CID_81261 | ||
| 0.071 | 0.014 | 0.071 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.082 | 0.025 | 0.082 | Carbonic anhydrase stimulant | |||
| 0.066 | 0.009 | 0.066 | GABA B receptor antagonist | |||
| 0.069 | 0.012 | 0.069 | Histone deacetylase class I inhibitor | |||
| 0.091 | 0.035 | 0.091 | Transforming growth factor beta 3 antagonist | |||
| 0.063 | 0.006 | 0.063 | Integrin alpha2 antagonist | |||
| 0.112 | 0.056 | 0.112 | CDC-like kinase 3 inhibitor | |||
| 0.154 | 0.098 | 0.212 | Death-associated protein kinase 2 inhibitor | 0.212 0.027 CID_81261 | CID_81261 | |
| 0.087 | 0.032 | 0.087 | Carbonic anhydrase inhibitor | |||
| 0.063 | 0.008 | 0.063 | Glutamate (mGluR3) antagonist | |||
| 0.067 | 0.011 | 0.067 | Glutamate (mGluR4) antagonist | 0.057 0.015 CID_81261 | ||
| 0.102 | 0.047 | 0.102 | Calcium antagonist | |||
| 0.094 | 0.039 | 0.094 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | |||
| 0.065 | 0.011 | 0.065 | Glutamate (mGluR group III) antagonist | 0.051 0.02 CID_81261 | ||
| 0.068 | 0.013 | 0.068 | Phosphodiesterase 7A inhibitor | |||
| 0.084 | 0.03 | 0.084 | Adenosine A2a receptor antagonist | |||
| 0.077 | 0.022 | 0.077 | Urokinase inhibitor | |||
| 0.073 | 0.019 | 0.073 | Factor IXa inhibitor | |||
| 0.086 | 0.031 | 0.086 | Potassium channel large-conductance Ca-activated activator | |||
| 0.086 | 0.032 | 0.086 | CDC7 inhibitor | |||
| 0.058 | 0.004 | 0.058 | Alpha 2a adrenoreceptor agonist | 0.017 0.012 CID_81261 | ||
| 0.076 | 0.022 | 0.076 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.07 | 0.017 | 0.07 | Potassium channel (Inward rectifier) blocker | |||
| 0.075 | 0.023 | 0.075 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.074 | 0.021 | 0.074 | Botulinum neurotoxin type A inhibitor | 0.073 0.023 CID_81261 | ||
| 0.076 | 0.023 | 0.076 | Ornithine carbamoyltransferase inhibitor | |||
| 0.068 | 0.015 | 0.068 | Carbonic anhydrase IV inhibitor | |||
| 0.073 | 0.021 | 0.073 | Sphingosine kinase inhibitor | |||
| 0.059 | 0.007 | 0.059 | Endothelial nitric-oxide synthase inhibitor | |||
| 0.072 | 0.02 | 0.072 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.05 0.043 CID_81261 | ||
| 0.06 | 0.008 | 0.06 | Histamine H1 receptor agonist | |||
| 0.081 | 0.029 | 0.081 | Protein kinase C beta inhibitor | |||
| 0.09 | 0.038 | 0.09 | Keratolytic | 0.075 0.055 CID_81261 | ||
| 0.074 | 0.023 | 0.074 | Pim-2 kinase inhibitor | |||
| 0.117 | 0.067 | 0.117 | Calcium channel N-type blocker | |||
| 0.085 | 0.035 | 0.085 | Benzodiazepine agonist | |||
| 0.129 | 0.078 | 0.129 | Tyrosine-protein kinase receptor antagonist | |||
| 0.066 | 0.016 | 0.066 | Factor VIIa inhibitor | |||
| 0.097 | 0.047 | 0.097 | Ornithine decarboxylase inhibitor | |||
| 0.212 | 0.163 | 0.212 | Antithrombotic | |||
| 0.13 | 0.08 | 0.13 | Histone deacetylase SIRT1 inhibitor | |||
| 0.057 | 0.008 | 0.057 | Hypoxanthine phosphoribosyltransferase inhibitor | |||
| 0.076 | 0.027 | 0.076 | Carbonic anhydrase XII inhibitor | |||
| 0.064 | 0.016 | 0.076 | Glucose-6-phosphate isomerase inhibitor | 0.076 0.01 CID_81261 | CID_81261 | |
| 0.062 | 0.014 | 0.062 | Dopamine beta hydroxylase inhibitor | 0.049 0.033 CID_81261 | ||
| 0.083 | 0.035 | 0.083 | Vanilloid 4 agonist | |||
| 0.054 | 0.006 | 0.054 | Dopamine autoreceptor agonist | |||
| 0.091 | 0.044 | 0.091 | Adrenaline agonist | |||
| 0.075 | 0.027 | 0.075 | Carbonic anhydrase I inhibitor | |||
| 0.075 | 0.027 | 0.075 | Carbonic anhydrase II inhibitor | |||
| 0.087 | 0.04 | 0.087 | Rho-associated kinase I inhibitor | |||
| 0.163 | 0.115 | 0.163 | Growth factor agonist | |||
| 0.055 | 0.009 | 0.055 | Heme oxygenase inhibitor | |||
| 0.063 | 0.017 | 0.063 | Histamine H4 receptor antagonist | |||
| 0.08 | 0.034 | 0.08 | Adenosine A2 receptor antagonist | |||
| 0.071 | 0.025 | 0.071 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.074 | 0.028 | 0.074 | Beta 3 adrenoreceptor antagonist | |||
| 0.09 | 0.045 | 0.09 | Glutamate receptor agonist | |||
| 0.091 | 0.046 | 0.091 | TIE-2 antagonist | |||
| 0.076 | 0.031 | 0.076 | Aryl hydrocarbon receptor antagonist | |||
| 0.063 | 0.018 | 0.073 | Adenosine deaminase inhibitor | 0.073 0.012 CID_81261 | CID_81261 | |
| 0.092 | 0.047 | 0.092 | TIE antagonist | |||
| 0.054 | 0.01 | 0.054 | Kainate receptor agonist | 0.045 0.021 CID_81261 | ||
| 0.092 | 0.047 | 0.092 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | |||
| 0.051 | 0.006 | 0.051 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.103 | 0.059 | 0.103 | Butyrylcholinesterase inhibitor | |||
| 0.048 | 0.004 | 0.048 | Integrin alpha2beta1 antagonist | |||
| 0.055 | 0.012 | 0.055 | Vascular adhesion protein 1 inhibitor | |||
| 0.055 | 0.011 | 0.226 | Histone deacetylase 1 inhibitor | 0.226 0.005 CID_81261 | CID_81261 | |
| 0.091 | 0.048 | 0.091 | MAP-kinase-activated kinase inhibitor | |||
| 0.07 | 0.027 | 0.07 | Histone deacetylase SIRT3 inhibitor | |||
| 0.065 | 0.022 | 0.065 | Alpha-mannosidase inhibitor | 0.055 0.034 CID_81261 | ||
| 0.088 | 0.045 | 0.088 | Caspase 7 inhibitor | |||
| 0.054 | 0.011 | 0.054 | Potassium channel Kv1.1 blocker | |||
| 0.055 | 0.012 | 0.055 | Phosphoglycerate kinase inhibitor | |||
| 0.054 | 0.013 | 0.054 | Inosine monophosphate dehydrogenase inhibitor | |||
| 0.067 | 0.026 | 0.067 | Alpha tubulin antagonist | |||
| 0.045 | 0.004 | 0.045 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.053 | 0.012 | 0.053 | Fumarate hydratase inhibitor | |||
| 0.094 | 0.054 | 0.094 | Polo-like kinase-1 inhibitor | |||
| 0.117 | 0.077 | 0.117 | c-Src kinase inhibitor | |||
| 0.057 | 0.017 | 0.057 | Purinergic P2X4 antagonist | |||
| 0.049 | 0.009 | 0.049 | AMPA 3 receptor antagonist | |||
| 0.047 | 0.007 | 0.047 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.062 | 0.022 | 0.062 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.122 | 0.082 | 0.122 | Interleukin 4 antagonist | |||
| 0.096 | 0.056 | 0.096 | Protein kinase C delta inhibitor | |||
| 0.066 | 0.027 | 0.066 | Cyclin A1 inhibitor | |||
| 0.113 | 0.074 | 0.113 | Topoisomerase II inhibitor | |||
| 0.078 | 0.039 | 0.078 | Potassium channel (Tandem pore domain) blocker | |||
| 0.066 | 0.027 | 0.066 | Toll-Like receptor 8 antagonist | |||
| 0.053 | 0.014 | 0.053 | Kainate receptor 2 antagonist | |||
| 0.105 | 0.066 | 0.105 | Granulocyte macrophage colony stimulating factor antagonist | |||
| 0.085 | 0.046 | 0.085 | Na+ K+ transporting ATPase inhibitor | 0.066 0.064 CID_81261 | ||
| 0.056 | 0.017 | 0.056 | Benzodiazepine antagonist | |||
| 0.076 | 0.037 | 0.076 | Protein kinase C alpha inhibitor | |||
| 0.049 | 0.011 | 0.049 | Glutamate (mGluR4) agonist | |||
| 0.122 | 0.084 | 0.122 | Vanilloid 1 agonist | |||
| 0.051 | 0.014 | 0.051 | Retinoid X alpha receptor agonist | |||
| 0.055 | 0.018 | 0.055 | CDK5/p25 inhibitor | |||
| 0.062 | 0.024 | 0.062 | Phosphorylase inhibitor | |||
| 0.066 | 0.029 | 0.066 | Beta 2 adrenoreceptor agonist | |||
| 0.081 | 0.044 | 0.081 | MAP-kinase-activated kinase 2 inhibitor | |||
| 0.06 | 0.023 | 0.06 | Heparanase inhibitor | |||
| 0.041 | 0.004 | 0.041 | Complement factor 1s inhibitor | 0.026 0.017 CID_81261 | ||
| 0.072 | 0.035 | 0.072 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.051 | 0.015 | 0.051 | Acid-sensing ion channel blocker | 0.05 0.016 CID_81261 | ||
| 0.056 | 0.019 | 0.056 | Dihydroorotase inhibitor | |||
| 0.042 | 0.006 | 0.042 | Purinergic P2Y15 antagonist | 0.037 0.008 CID_81261 | ||
| 0.075 | 0.039 | 0.075 | Acetylcholine M5 receptor agonist | |||
| 0.202 | 0.166 | 0.202 | Caspase 3 stimulant | |||
| 0.041 | 0.005 | 0.041 | Estrogen-related receptor gamma antagonist | |||
| 0.103 | 0.067 | 0.103 | AMP-activated protein kinase stimulant | |||
| 0.109 | 0.073 | 0.109 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.046 | 0.01 | 0.046 | Cyclin E2 inhibitor | |||
| 0.053 | 0.018 | 0.053 | Guanylate cyclase inhibitor | |||
| 0.055 | 0.02 | 0.055 | Mannosidase inhibitor | 0.043 0.034 CID_81261 | ||
| 0.04 | 0.005 | 0.04 | Glutamate (mGluR1a) agonist | |||
| 0.053 | 0.018 | 0.053 | Glutamate (mGluR1a) antagonist | |||
| 0.087 | 0.052 | 0.087 | GABA A receptor agonist | |||
| 0.058 | 0.023 | 0.058 | Potassium channel (Inward rectifier) activator | |||
| 0.063 | 0.029 | 0.063 | NMDA 2B receptor antagonist | |||
| 0.075 | 0.041 | 0.075 | Neuronal nicotinic receptor antagonist | |||
| 0.088 | 0.054 | 0.088 | Protein kinase A inhibitor | |||
| 0.055 | 0.022 | 0.055 | Potassium channel (ATP-sensitive) activator | |||
| 0.049 | 0.016 | 0.049 | GABA uptake inhibitor | |||
| 0.118 | 0.086 | 0.118 | Cyclin-dependent kinase 7 inhibitor | |||
| 0.048 | 0.017 | 0.048 | Delayed rectifier potassium channel activator | |||
| 0.048 | 0.017 | 0.048 | Potassium channel KCNQ activator | |||
| 0.047 | 0.015 | 0.229 | Histone deacetylase 2 inhibitor | 0.229 0.006 CID_81261 | CID_81261 | |
| 0.041 | 0.01 | 0.041 | CDK4/cyclin D3 inhibitor | |||
| 0.131 | 0.1 | 0.131 | Phospholipase A2 inhibitor | |||
| 0.044 | 0.013 | 0.044 | Purinergic P2Y2 antagonist | |||
| 0.097 | 0.066 | 0.097 | Insulin receptor antagonist | |||
| 0.081 | 0.05 | 0.081 | Macrophage migration inhibitory factor inhibitor | |||
| 0.079 | 0.049 | 0.079 | Alpha 2a adrenoreceptor antagonist | |||
| 0.082 | 0.052 | 0.082 | Acetylcholine nicotinic antagonist | |||
| 0.054 | 0.024 | 0.054 | Carbonic anhydrase VII inhibitor | |||
| 0.058 | 0.028 | 0.058 | Diacylglycerol O-acyltransferase inhibitor | |||
| 0.034 | 0.004 | 0.034 | Alpha 2c adrenoreceptor agonist | |||
| 0.068 | 0.039 | 0.068 | 5 Hydroxytryptamine 2A agonist | |||
| 0.041 | 0.011 | 0.041 | Adenosine uptake inhibitor | |||
| 0.092 | 0.063 | 0.092 | Breast cancer-resistant protein inhibitor | |||
| 0.048 | 0.019 | 0.048 | Plasmepsin II inhibitor | |||
| 0.117 | 0.088 | 0.117 | Sodium channel blocker | |||
| 0.117 | 0.088 | 0.117 | Sodium channel (voltage-gated) blocker | |||
| 0.064 | 0.036 | 0.064 | Androgen agonist | |||
| 0.034 | 0.005 | 0.034 | Imidazoline I1 receptor antagonist | |||
| 0.048 | 0.02 | 0.048 | Thymidine kinase inhibitor | |||
| 0.037 | 0.009 | 0.037 | 5 Hydroxytryptamine 6 agonist | |||
| 0.06 | 0.031 | 0.06 | Pregnane X receptor antagonist | |||
| 0.04 | 0.012 | 0.04 | Protein kinase (CK2) beta inhibitor | |||
| 0.058 | 0.03 | 0.058 | Histamine agonist | |||
| 0.097 | 0.069 | 0.097 | Gastric antisecretory | |||
| 0.06 | 0.032 | 0.06 | 5 Hydroxytryptamine 7 agonist | |||
| 0.045 | 0.017 | 0.045 | 5 Hydroxytryptamine 2B agonist | |||
| 0.037 | 0.009 | 0.037 | MAP3K8 inhibitor | |||
| 0.058 | 0.031 | 0.058 | Nicotinic receptor alpha7 subunit antagonist | |||
| 0.039 | 0.011 | 0.039 | Nicotinic alpha3beta4 receptor agonist | |||
| 0.083 | 0.056 | 0.083 | Glutathione S-transferase inhibitor | |||
| 0.091 | 0.064 | 0.091 | ABCA1 expression enhancer | |||
| 0.085 | 0.058 | 0.085 | Bcr-Abl kinase inhibitor | |||
| 0.135 | 0.108 | 0.135 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | |||
| 0.057 | 0.03 | 0.057 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.059 | 0.033 | 0.059 | MAP kinase kinase 9 inhibitor | |||
| 0.086 | 0.059 | 0.086 | Acetylcholine agonist | |||
| 0.033 | 0.008 | 0.033 | Complement factor 1r inhibitor | |||
| 0.057 | 0.032 | 0.057 | DNA helicase inhibitor | |||
| 0.058 | 0.033 | 0.058 | Glucosylceramidase inhibitor | |||
| 0.045 | 0.02 | 0.048 | Histone deacetylase 9 inhibitor | 0.048 0.017 CID_81261 | CID_81261 | |
| 0.063 | 0.038 | 0.063 | Phosphodiesterase 1B inhibitor | |||
| 0.046 | 0.021 | 0.046 | Sphingosine kinase 1 inhibitor | |||
| 0.033 | 0.009 | 0.033 | Hedgehog signaling activator | |||
| 0.033 | 0.009 | 0.033 | Adenosine kinase inhibitor | |||
| 0.038 | 0.014 | 0.038 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.06 | 0.036 | 0.06 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.036 | 0.012 | 0.036 | Lysine carboxypeptidase inhibitor | |||
| 0.034 | 0.01 | 0.034 | NMDA receptor glycine site antagonist | |||
| 0.038 | 0.014 | 0.038 | ATR kinase inhibitor | |||
| 0.035 | 0.012 | 0.035 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.062 | 0.039 | 0.062 | Beta tubulin antagonist | |||
| 0.044 | 0.021 | 0.044 | Glutamate (mGluR group II) antagonist | |||
| 0.077 | 0.054 | 0.077 | MAP kinase 7 inhibitor | |||
| 0.028 | 0.005 | 0.028 | NMDA receptor phencyclidine site antagonist | |||
| 0.121 | 0.098 | 0.121 | Cyclooxygenase inhibitor | |||
| 0.043 | 0.02 | 0.043 | Arginase inhibitor | |||
| 0.044 | 0.021 | 0.044 | Membrane dipeptidase inhibitor | 0.036 0.033 CID_81261 | ||
| 0.054 | 0.031 | 0.054 | Beta 2 adrenoreceptor antagonist | |||
| 0.089 | 0.067 | 0.089 | MAO B inhibitor | |||
| 0.031 | 0.009 | 0.031 | Acid ceramidase inhibitor | |||
| 0.084 | 0.062 | 0.084 | Alpha 2 adrenoreceptor antagonist | |||
| 0.11 | 0.088 | 0.11 | M17 leucyl aminopeptidase inhibitor | |||
| 0.036 | 0.014 | 0.036 | Glutamate (mGluR3) agonist | |||
| 0.037 | 0.015 | 0.037 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.042 | 0.021 | 0.042 | Retinoid X receptor agonist | |||
| 0.052 | 0.031 | 0.052 | Adenosine A2b receptor antagonist | |||
| 0.027 | 0.006 | 0.027 | Factor XIII inhibitor | |||
| 0.083 | 0.062 | 0.083 | Androgen antagonist | |||
| 0.042 | 0.022 | 0.055 | Histone deacetylase 7 inhibitor | 0.055 0.017 CID_81261 | CID_81261 | |
| 0.109 | 0.088 | 0.109 | TRKB antagonist | |||
| 0.096 | 0.076 | 0.096 | Beta glucuronidase inhibitor | |||
| 0.091 | 0.07 | 0.091 | Xanthine oxidase inhibitor | |||
| 0.072 | 0.052 | 0.072 | Cathepsin G inhibitor | |||
| 0.06 | 0.04 | 0.06 | Phosphodiesterase 1A inhibitor | |||
| 0.036 | 0.017 | 0.036 | Factor VII inhibitor | |||
| 0.036 | 0.017 | 0.036 | Acetylcholine M4 receptor agonist | |||
| 0.034 | 0.014 | 0.034 | Thrombin receptor antagonist | |||
| 0.035 | 0.017 | 0.035 | AMPA 1 receptor antagonist | |||
| 0.058 | 0.04 | 0.058 | Dopamine uptake inhibitor | |||
| 0.075 | 0.057 | 0.075 | Topoisomerase II alpha inhibitor | |||
| 0.044 | 0.026 | 0.044 | Angiotensin AT1 receptor antagonist | |||
| 0.027 | 0.009 | 0.027 | Inosine monophosphate dehydrogenase 2 inhibitor | |||
| 0.096 | 0.078 | 0.096 | Cyclin-dependent kinase 5 inhibitor | |||
| 0.058 | 0.04 | 0.058 | Glutamate (mGluR1) antagonist | |||
| 0.068 | 0.05 | 0.068 | Protein kinase B alpha inhibitor | |||
| 0.022 | 0.004 | 0.022 | CDK2/cyclin A3 inhibitor | |||
| 0.065 | 0.048 | 0.065 | 5 Hydroxytryptamine 3A antagonist | |||
| 0.029 | 0.011 | 0.029 | Glutamate (mGluR1) agonist | |||
| 0.105 | 0.087 | 0.105 | Protein kinase (CK1) delta inhibitor | |||
| 0.045 | 0.028 | 0.045 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.05 | 0.033 | 0.05 | Squalene epoxidase inhibitor | |||
| 0.023 | 0.006 | 0.023 | Antibiotic Anthracycline-like | |||
| 0.029 | 0.012 | 0.029 | Thymidine phosphorylase inhibitor | |||
| 0.046 | 0.03 | 0.046 | Purinergic P2Y antagonist | |||
| 0.029 | 0.012 | 0.029 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.023 | 0.007 | 0.023 | Estrogen-related receptor gamma agonist | |||
| 0.041 | 0.025 | 0.041 | Urate transporter 1 inhibitor | |||
| 0.023 | 0.007 | 0.023 | Nicotinic acid receptor 1 antagonist | |||
| 0.054 | 0.038 | 0.054 | Nicotinic alpha7 receptor agonist | |||
| 0.035 | 0.02 | 0.035 | Melatonin receptor 1A agonist | |||
| 0.048 | 0.032 | 0.048 | Aldosterone antagonist | |||
| 0.043 | 0.028 | 0.043 | DNA gyrase subunit A inhibitor | |||
| 0.087 | 0.071 | 0.087 | CDK2/cyclin A inhibitor | |||
| 0.022 | 0.007 | 0.022 | Complement factor D inhibitor | |||
| 0.102 | 0.087 | 0.102 | Histone deacetylase class III inhibitor | |||
| 0.04 | 0.025 | 0.04 | MAP3K5 inhibitor | |||
| 0.05 | 0.035 | 0.05 | Factor III inhibitor | |||
| 0.031 | 0.016 | 0.031 | Nicotinic alpha4beta2 receptor agonist | |||
| 0.043 | 0.029 | 0.043 | Oxytocin agonist | |||
| 0.028 | 0.014 | 0.028 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.039 | 0.025 | 0.039 | Vanilloid 3 antagonist | |||
| 0.032 | 0.018 | 0.032 | Glutamate (mGluR2) antagonist | |||
| 0.221 | 0.208 | 0.221 | Transcription factor inhibitor | |||
| 0.028 | 0.015 | 0.114 | Histone deacetylase 3 inhibitor | 0.114 0.007 CID_81261 | CID_81261 | |
| 0.023 | 0.009 | 0.023 | Toll-Like receptor 8 agonist | |||
| 0.036 | 0.023 | 0.036 | Opioid delta receptor agonist | |||
| 0.024 | 0.012 | 0.024 | Isoleucine-tRNA ligase inhibitor | |||
| 0.022 | 0.009 | 0.022 | Cyclin T1 inhibitor | |||
| 0.022 | 0.01 | 0.022 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.039 | 0.027 | 0.039 | Protein kinase (CK1) epsilon inhibitor | |||
| 0.06 | 0.048 | 0.06 | Trypsin inhibitor | |||
| 0.062 | 0.051 | 0.062 | Beta adrenoreceptor antagonist | |||
| 0.036 | 0.025 | 0.036 | Nicotinic acid receptor agonist | |||
| 0.028 | 0.016 | 0.028 | Glucosylceramidase stimulant | |||
| 0.029 | 0.017 | 0.029 | LFA antagonist | |||
| 0.054 | 0.043 | 0.054 | Xanthine dehydrogenase inhibitor | |||
| 0.036 | 0.025 | 0.036 | 5 Hydroxytryptamine 3B antagonist | |||
| 0.034 | 0.022 | 0.034 | Sirtuin 2 inhibitor | |||
| 0.104 | 0.093 | 0.104 | RET inhibitor | |||
| 0.056 | 0.044 | 0.056 | CDK9/cyclin T1 inhibitor | |||
| 0.028 | 0.016 | 0.028 | Nicotinic acid receptor 2 antagonist | |||
| 0.019 | 0.008 | 0.019 | Purinergic P2Y1 agonist | |||
| 0.022 | 0.012 | 0.022 | Neuraminidase (Influenza B) inhibitor | |||
| 0.131 | 0.12 | 0.131 | Antipruritic | |||
| 0.099 | 0.089 | 0.099 | Proteasome inhibitor | |||
| 0.053 | 0.043 | 0.053 | Beta 1 adrenoreceptor antagonist | |||
| 0.218 | 0.207 | 0.218 | Alpha-glucosidase inhibitor | |||
| 0.015 | 0.005 | 0.015 | Imidazoline I2 receptor antagonist | |||
| 0.02 | 0.01 | 0.02 | Methylmalonyl-CoA mutase inhibitor | |||
| 0.04 | 0.03 | 0.046 | Histone deacetylase 8 inhibitor | 0.046 0.025 CID_81261 | CID_81261 | |
| 0.02 | 0.01 | 0.02 | Alpha 2b adrenoreceptor agonist | |||
| 0.027 | 0.018 | 0.027 | Calcium-sensing receptor agonist | |||
| 0.023 | 0.013 | 0.023 | Glutaminyl-peptide cyclotransferase inhibitor | |||
| 0.062 | 0.053 | 0.062 | Cyclin B3 inhibitor | |||
| 0.012 | 0.003 | 0.012 | DNA topoisomerase III inhibitor | 0.007 0.006 CID_81261 | ||
| 0.039 | 0.03 | 0.039 | DNA-dependent protein kinase inhibitor | |||
| 0.058 | 0.049 | 0.058 | Cyclin A2 inhibitor | |||
| 0.025 | 0.017 | 0.025 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.032 | 0.023 | 0.032 | Dipeptidyl peptidase II inhibitor | |||
| 0.1 | 0.091 | 0.1 | Acetylcholine muscarinic antagonist | |||
| 0.025 | 0.016 | 0.025 | 5 Hydroxytryptamine 4 agonist | |||
| 0.023 | 0.014 | 0.023 | Protease (Human cytomegalovirus) inhibitor | |||
| 0.033 | 0.025 | 0.033 | Angiotensin II receptor antagonist | |||
| 0.044 | 0.036 | 0.044 | Beta adrenoreceptor agonist | |||
| 0.023 | 0.015 | 0.023 | ICAM 1 antagonist | |||
| 0.048 | 0.04 | 0.048 | mTOR inhibitor | |||
| 0.04 | 0.033 | 0.04 | Leukocyte elastase inhibitor | |||
| 0.014 | 0.007 | 0.014 | Glutamate (mGluR6) agonist | |||
| 0.098 | 0.09 | 0.098 | Activin receptor-like kinase 4 inhibitor | |||
| 0.014 | 0.007 | 0.108 | Human herpes virus 5 capsid protein P40 inhibitor | 0.108 0.002 CID_81261 | CID_81261 | |
| 0.092 | 0.085 | 0.092 | Toll-Like receptor 4 antagonist | |||
| 0.035 | 0.028 | 0.035 | Glutamate (mGluR8) antagonist | |||
| 0.025 | 0.018 | 0.025 | Vanilloid 2 agonist | |||
| 0.018 | 0.011 | 0.032 | Ileal bile acid transport inhibitor | 0.032 0.005 CID_81261 | CID_81261 | |
| 0.089 | 0.083 | 0.089 | Mediator release inhibitor | |||
| 0.047 | 0.041 | 0.047 | Dihydroorotate dehydrogenase inhibitor | |||
| 0.047 | 0.041 | 0.047 | Prolyl endopeptidase inhibitor | |||
| 0.053 | 0.047 | 0.053 | Alpha 1 adrenoreceptor agonist | |||
| 0.017 | 0.01 | 0.017 | Adenosine A2 receptor agonist | |||
| 0.054 | 0.048 | 0.054 | Leukotriene C antagonist | |||
| 0.058 | 0.053 | 0.062 | Neutrophil collagenase inhibitor | 0.062 0.048 CID_81261 | CID_81261 | |
| 0.068 | 0.063 | 0.068 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | |||
| 0.089 | 0.084 | 0.089 | Cyclin-dependent kinase 2 inhibitor | |||
| 0.066 | 0.06 | 0.066 | Histone deacetylase SIRT2 inhibitor | |||
| 0.026 | 0.021 | 0.026 | Uridine phosphorylase inhibitor | |||
| 0.07 | 0.065 | 0.07 | Fibroblast growth factor 3 antagonist | |||
| 0.031 | 0.026 | 0.031 | Carboxypeptidase B inhibitor | |||
| 0.05 | 0.045 | 0.05 | Leukotriene B4 antagonist | |||
| 0.011 | 0.006 | 0.011 | Angiotensin AT2 receptor agonist | |||
| 0.045 | 0.04 | 0.045 | Transforming growth factor beta 1 antagonist | |||
| 0.025 | 0.021 | 0.025 | Purinergic P2X agonist | |||
| 0.052 | 0.048 | 0.052 | Kallikrein 1 inhibitor | |||
| 0.013 | 0.009 | 0.02 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.02 0.004 CID_81261 | CID_81261 | |
| 0.031 | 0.027 | 0.031 | Calcium release-activated channel blocker | |||
| 0.055 | 0.051 | 0.055 | Acetylcholine M5 receptor antagonist | |||
| 0.026 | 0.022 | 0.026 | Liver X receptor beta antagonist | |||
| 0.013 | 0.009 | 0.013 | Cyclin D2 inhibitor | |||
| 0.015 | 0.011 | 0.015 | Thromboxane A2 agonist | |||
| 0.094 | 0.091 | 0.094 | Aurora-B kinase inhibitor | |||
| 0.064 | 0.061 | 0.064 | Rho-associated kinase inhibitor | |||
| 0.053 | 0.05 | 0.053 | Cyclin A inhibitor | |||
| 0.066 | 0.063 | 0.066 | Protein kinase B gamma inhibitor | |||
| 0.012 | 0.009 | 0.012 | Carbonic anhydrase XI inhibitor | |||
| 0.014 | 0.011 | 0.014 | Adenosine A2a receptor agonist | |||
| 0.016 | 0.013 | 0.016 | Carbonic anhydrase X inhibitor | |||
| 0.016 | 0.013 | 0.016 | Carbonic anhydrase VIII inhibitor | |||
| 0.007 | 0.004 | 0.007 | CC chemokine 6 receptor agonist | |||
| 0.028 | 0.026 | 0.028 | Epoxide hydrolase 1 inhibitor | |||
| 0.029 | 0.027 | 0.029 | Estrogen-related receptor alpha antagonist | |||
| 0.051 | 0.049 | 0.051 | EphB4 antagonist | |||
| 0.025 | 0.023 | 0.025 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | |||
| 0.016 | 0.014 | 0.016 | Telomerase stimulant | |||
| 0.047 | 0.045 | 0.047 | Alpha 1b adrenoreceptor agonist | |||
| 0.049 | 0.047 | 0.049 | Nicotinic neuronal receptor agonist | |||
| 0.032 | 0.031 | 0.032 | Ceramide glucosyltransferase inhibitor | |||
| 0.025 | 0.024 | 0.025 | 5 Hydroxytryptamine 1D agonist | |||
| 0.07 | 0.068 | 0.082 | Estrogen receptor alpha antagonist | 0.082 0.046 CID_81261 | CID_81261 | |
| 0.026 | 0.025 | 0.026 | AMPA 2 receptor antagonist | |||
| 0.065 | 0.064 | 0.065 | MAP3K7 inhibitor | |||
| 0.07 | 0.069 | 0.07 | Platelet growth factor antagonist | |||
| 0.03 | 0.029 | 0.03 | Free fatty acid receptor 1 antagonist | |||
| 0.033 | 0.032 | 0.033 | Kinesin-like protein 1 inhibitor | |||
| 0.033 | 0.032 | 0.033 | Kinesin antagonist | |||
| 0.03 | 0.029 | 0.03 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.044 | 0.058 | 0.055 | Matrix metalloproteinase (membrane-type) inhibitor | 0.055 0.039 CID_81261 | CID_81261 | |
| 0.035 | 0.055 | 0.05 | Metalloproteinase-3 inhibitor | 0.05 0.034 CID_81261 | CID_81261 | |
| 0.06 | 0.083 | 0.067 | Metalloproteinase-9 inhibitor | 0.067 0.061 CID_81261 | CID_81261 | |
| 0.02 | 0.044 | 0.028 | Peptide deformylase inhibitor | 0.028 0.024 CID_81261 | CID_81261 | |
| 0.014 | 0.046 | 0.085 | Histone deacetylase 10 inhibitor | 0.085 0.006 CID_81261 | CID_81261 | |
| 0.112 | 0.146 | 0.127 | Death-associated protein kinase 1 inhibitor | 0.127 0.089 CID_81261 | CID_81261 | |
| 0.057 | 0.092 | 0.086 | Metalloproteinase-2 inhibitor | 0.086 0.047 CID_81261 | CID_81261 | |
| 0.04 | 0.083 | 0.064 | Matrix metalloproteinase inhibitor | 0.064 0.049 CID_81261 | CID_81261 | |
| 0.034 | 0.078 | 0.111 | Aminopeptidase microsomal inhibitor | 0.111 0.015 CID_81261 | CID_81261 | |
| 0.023 | 0.075 | 0.094 | Aminopeptidase N inhibitor | 0.094 0.014 CID_81261 | CID_81261 | |
| 0.037 | 0.096 | 0.067 | Collagenase 3 inhibitor | 0.067 0.035 CID_81261 | CID_81261 | |
| 0.024 | 0.088 | 0.046 | Matrix metalloproteinase 1 inhibitor | 0.046 0.041 CID_81261 | CID_81261 | |
| 0.014 | 0.084 | 0.09 | Histone deacetylase class IV inhibitor | 0.09 0.006 CID_81261 | CID_81261 | |
| 0.014 | 0.084 | 0.09 | Histone deacetylase 11 inhibitor | 0.09 0.006 CID_81261 | CID_81261 | |
| 0.01 | 0.085 | 0.176 | Histone deacetylase 5 inhibitor | 0.176 0.006 CID_81261 | CID_81261 | |
| 0.017 | 0.1 | 0.065 | Dopamine D2 agonist | 0.065 0.019 CID_81261 | CID_81261 | |
| 0.009 | 0.106 | 0.149 | Histone deacetylase class IIa inhibitor | 0.149 0.006 CID_81261 | CID_81261 | |
| 0.11 | 0.217 | 0.359 | Tumour necrosis factor alpha release inhibitor | 0.359 0.036 CID_81261 | CID_81261 | |
| 0.056 | 0.177 | 0.095 | Estrogen receptor beta antagonist | 0.095 0.075 CID_81261 | CID_81261 | |
| 0.015 | 0.14 | 0.061 | Macrophage elastase inhibitor | 0.061 0.018 CID_81261 | CID_81261 | |
| 0.008 | 0.142 | 0.178 | Histone deacetylase class II inhibitor | 0.178 0.005 CID_81261 | CID_81261 | |
| 0.041 | 0.186 | 0.226 | 5-Lipoxygenase inhibitor | 0.226 0.02 CID_81261 | CID_81261 | |
| 0.008 | 0.189 | 0.081 | Histone deacetylase 4 inhibitor | 0.081 0.007 CID_81261 | CID_81261 | |
| 0.006 | 0.197 | 0.176 | Histone deacetylase class IIb inhibitor | 0.176 0.005 CID_81261 | CID_81261 | |
| 0.006 | 0.208 | 0.174 | Histone deacetylase 6 inhibitor | 0.174 0.005 CID_81261 | CID_81261 | |
| 0.01 | 0.26 | 0.067 | Collagenase inhibitor | 0.067 0.011 CID_81261 | CID_81261 | |
| 0.015 | 0.306 | 0.069 | ADAM10 endopeptidase inhibitor | 0.069 0.005 CID_81261 | CID_81261 | |
| 0.013 | 0.461 | 0.048 | Aggrecanase 1 inhibitor | 0.048 0.015 CID_81261 | CID_81261 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |